TD Waterhouse Canada’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $805K | Sell |
20,678
-127
| -0.6% | -$4.95K | 0.01% | 572 |
|
|
2025
Q1 | $788K | Sell |
20,805
-158
| -0.8% | -$5.98K | 0.01% | 565 |
|
|
2024
Q4 | $709K | Buy |
20,963
+1,332
| +7% | +$45K | 0.01% | 562 |
|
|
2024
Q3 | $791K | Buy |
19,631
+1,779
| +10% | +$71.6K | 0.01% | 538 |
|
|
2024
Q2 | $686K | Buy |
17,852
+81
| +0.5% | +$3.11K | 0.01% | 547 |
|
|
2024
Q1 | $776K | Sell |
17,771
-616
| -3% | -$26.9K | 0.01% | 546 |
|
|
2023
Q4 | $750K | Buy |
18,387
+374
| +2% | +$15.3K | 0.01% | 465 |
|
|
2023
Q3 | $680K | Sell |
18,013
-805
| -4% | -$30.4K | 0.01% | 476 |
|
|
2023
Q2 | $681K | Buy |
18,818
+1,522
| +9% | +$55.1K | 0.01% | 478 |
|
|
2023
Q1 | $638K | Buy |
17,296
+242
| +1% | +$8.93K | 0.01% | 489 |
|
|
2022
Q4 | $617K | Sell |
17,054
-1,542
| -8% | -$55.8K | 0.01% | 488 |
|
|
2022
Q3 | $571K | Buy |
18,596
+785
| +4% | +$24.1K | 0.01% | 483 |
|
|
2022
Q2 | $1M | Sell |
17,811
-3,030
| -15% | -$170K | 0.01% | 411 |
|
|
2022
Q1 | $1.15M | Sell |
20,841
-44,133
| -68% | -$2.44M | 0.01% | 423 |
|
|
2021
Q4 | $3.57M | Buy |
+64,974
| New | +$3.57M | 0.03% | 267 |
|